Potential Rett syndrome drug shows promising results in phase 3 trial

Dec. 6, 2021—A potential first-of-its-kind drug to treat the symptoms of Rett syndrome received positive top-line results from a phase 3 trial led by investigators from Vanderbilt University Medical Center to evaluate efficacy and safety.

Read more